Drug Profile
Goserelin implant - Mithra Pharmaceuticals
Alternative Names: Zoreline®Latest Information Update: 16 Mar 2022
Price :
$50
*
At a glance
- Originator Novalon
- Developer Mithra Pharmaceuticals; Novalon
- Class Antineoplastics; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Endometriosis; Prostate cancer
- Phase Unknown Breast cancer